Dapagliflozin Tablets 10 mg is an oral antidiabetic drug that selectively inhibits sodium-glucose cotransporter 2 (SGLT2) in the kidneys. It reduces reabsorption of filtered glucose and increases urinary glucose excretion, thereby lowering blood glucose levels independently of insulin.
Composition
Each film‑coated tablet contains:
Dapagliflozin …… 10 mg
Indications
For the treatment of adult patients with type 2 diabetes mellitus to improve glycemic control, used alone or in combination with other antidiabetic agents including insulin.
Also indicated for heart failure and chronic kidney disease in appropriate patients.
Key Features
Insulin‑independent glucose‑lowering mechanism
Once‑daily oral administration, high patient compliance
Associated with weight loss and mild blood pressure reduction
Cardiovascular and renal protective effects
Good safety profile and well‑tolerated
Complies with USP / EP / CP pharmacopoeial standards
Manufactured under strict GMP conditions
Complete registration dossiers available for global markets
Storage
Store in a cool, dry place, protected from light and moisture.
Keep out of reach of children.
